Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from CardieX Limited ( (AU:CDX) ).
Cardiex Limited announced that its CONNEQT Health subsidiary has integrated its health monitoring capabilities with the Apple Health app on iPhone, allowing users to access key arterial health biomarkers directly. This integration enhances the user experience by providing a more connected and personalized healthcare experience, enabling patients to manage their health more effectively and securely.
More about CardieX Limited
Cardiex Limited is a company focused on advancing medical technology in vascular health. It offers a range of products, including medical and home health devices and digital solutions, primarily targeting hypertension, cardiovascular disease, and other vascular health disorders. The company’s offerings are based on its proprietary SphygmoCor® vascular biomarker technology, and it is listed on the Australian Stock Exchange.
Technical Sentiment Signal: Sell
Current Market Cap: $20.39M
See more insights into CDX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue